StockData

VitaNova Life Sciences Corp (VNOV) stock

VNOVOTCWholesale-Apparel, Piece Goods & NotionsFiscal year ends April 30
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026Score 7/30
$4.50+0.50 (+12.50%)

Close on Oct 19, 2026Market cap $37.52MP/E –Yield –

VitaNova Life Sciences operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

VitaNova Life Sciences's operating income for the twelve months ending Jul 31, 2026 was -$86.12K, down 107.1% year over year. For fiscal 2026 it was $3.60K, down 99.7% from the year before. The highest annual figure on record is $1.21M in fiscal 2025.

Annual operating income

PeriodPeriod endValueChange
FY2026Apr 30, 2026$3.60K-99.7%
FY2025Apr 30, 2025$1.21M+487.6%
FY2024Apr 30, 2024$205.63K–
FY2023Apr 30, 2023-$24.23K–
FY2022Apr 30, 2022-$13.37K–
FY2021Apr 30, 2021-$52.09K–
FY2020Apr 30, 2020-$72.33K–
FY2019Apr 30, 2019-$71.81K–

Quarterly operating income

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ2 2026Jul 31, 2026-$122.16K–
Q4 FY2026CQ1 2026Apr 30, 2026-$109.86K-110.2%
Q3 FY2026CQ4 2025Jan 31, 2026$46.73K-57.1%
Q2 FY2026CQ3 2025Oct 31, 2025$99.17K+58.4%
Q1 FY2026CQ2 2025Jul 31, 2025-$32.44K–
Q4 FY2025CQ1 2025Apr 30, 2025$1.08M+365.1%
Q3 FY2025CQ4 2024Jan 31, 2025$108.87K+1730.4%
Q2 FY2025CQ3 2024Oct 31, 2024$62.60K–
Q1 FY2025CQ2 2024Jul 31, 2024-$45.41K–
Q4 FY2024CQ1 2024Apr 30, 2024$232.68K+10803.6%
Q3 FY2024CQ4 2023Jan 31, 2024$5.95K–
Q2 FY2024CQ3 2023Oct 31, 2023-$8.76K–
Q1 FY2024CQ2 2023Jul 31, 2023-$24.25K–
Q1 FY2023CQ2 2022Jul 31, 2022$2.13K–
Q2 FY2022CQ3 2021Oct 31, 2021-$29.99K–
Q1 FY2022CQ2 2021Jul 31, 2021-$10.49K–
Q4 FY2021CQ1 2021Apr 30, 2021-$25.56K–
Q3 FY2021CQ4 2020Jan 31, 2021-$2.90K–
Q2 FY2021CQ3 2020Oct 31, 2020-$12.39K–
Q1 FY2021CQ2 2020Jul 31, 2020-$11.25K–
Q4 FY2020CQ1 2020Apr 30, 2020-$26.34K–
Q3 FY2020CQ4 2019Jan 31, 2020-$6.59K–
Q2 FY2020CQ3 2019Oct 31, 2019-$19.52K–
Q1 FY2020CQ2 2019Jul 31, 2019-$19.88K–
Q4 FY2019CQ1 2019Apr 30, 2019-$13.60K–
Q1 FY2019CQ2 2018Jul 31, 2018-$15.83K–

More VitaNova Life Sciences figures

See a number that looks wrong?